Source: Annual Congress 2007 - Therapy of thoracic malignancies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. T. Stathopoulos, C. Moschos, A. Kollintza, I. Psallidas, H. Loutrari, S. Magkouta, H. Petrocheilou, P. Theodoropoulou, S. A. Papiris, C. Roussos, I. Kalomenidis (Athens, Greece). Zoledronic acid limits experimental malignant pleural effusion. Eur Respir J 2007; 30: Suppl. 51, 2552

Member's Comments

No comment yet.

Related content which might interest you: Cytological diagnosis of malignant mesothelioma – improvement by additional determination of hyaluronic acid in pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 783s Year: 2006 Hyaluronic acid levels are increased in parapneumonic pleural effusions Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Diagnostic efficiency of pleural fluid lipid-bound sialic acid level in malignant pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 439s Year: 2002 Tranexamic acid versus bleomycin pleurodesis for malignant pleural effusion via tube drainage Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 Pleurodesis in the treatment of malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004 All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice Source: Eur Respir J 2009; 34: 1159-1167 Year: 2009 Pleurodesis for malignant pleural effusion Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016 Pleurodesis for malignant pleural effusion Source: School Course 2014 - Medical Thoracoscopy Year: 2014 Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 The role of pleural aspirate acid fast bacilli in pleural effusion of unknown cause Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005 Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Pleurodesis for malignant pleural effusion: which compound? Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013 Pleurodesis for malignant pleural effusion: which compound? Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012 Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019 Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 541s Year: 2003